Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AK112”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07103447
What this trial is testing

Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC

Who this might be right for
Breast Cancer - Female
Shuangyue Liu 54
Early research (Phase 1)Active Not RecruitingNCT07340476
What this trial is testing

Evaluate the PK Similarity of AK112 in Healthy Chinese Male Subjects

Who this might be right for
Healthy Male Subjects
Akeso 108
Testing effectiveness (Phase 2)Looking for participantsNCT06718543
What this trial is testing

Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
fan li 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06593548
What this trial is testing

Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer

Who this might be right for
CRCMSSMetastatic Cancer
Fudan University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06196775
What this trial is testing

Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Harbin Medical University 36
Testing effectiveness (Phase 2)Looking for participantsNCT07052253
What this trial is testing

A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

Who this might be right for
Hepatocellular Carcinoma (HCC)
Akeso 100